These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11772424)

  • 21. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
    Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
    Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
    Takata Y; Kitami Y; Yang ZH; Nakamura M; Okura T; Hiwada K
    Circ Res; 2002 Sep; 91(5):427-33. PubMed ID: 12215492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of PPAR gamma (peroxisome proliferator-activated receptor gamma) in atherosclerosis].
    Itoh H; Nakao K
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():602-16. PubMed ID: 11351658
    [No Abstract]   [Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice.
    Torra IP; Chinetti G; Duval C; Fruchart JC; Staels B
    Curr Opin Lipidol; 2001 Jun; 12(3):245-54. PubMed ID: 11353326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-atherosclerotic effects of PPAR gamma ligands].
    Wakino S
    Nihon Rinsho; 2004 Jan; 62(1):180-6. PubMed ID: 14737851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptors: from genes to physiology.
    Kliewer SA; Xu HE; Lambert MH; Willson TM
    Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A; Gervois P; Pauletto P; Fruchart JC; Staels B
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):977-86. PubMed ID: 16424352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
    Diep QN; El Mabrouk M; Cohn JS; Endemann D; Amiri F; Virdis A; Neves MF; Schiffrin EL
    Circulation; 2002 May; 105(19):2296-302. PubMed ID: 12010913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications.
    Israelian-Konaraki Z; Reaven PD
    Cardiology; 2005; 103(1):1-9. PubMed ID: 15528894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
    Marx N; Libby P; Plutzky J
    J Cardiovasc Risk; 2001 Aug; 8(4):203-10. PubMed ID: 11550998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR).
    Bocos C; Göttlicher M; Gearing K; Banner C; Enmark E; Teboul M; Crickmore A; Gustafsson JA
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):467-73. PubMed ID: 7626496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma and atherosclerosis.
    Marx N
    Curr Hypertens Rep; 2002 Feb; 4(1):71-7. PubMed ID: 11790295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPAR alpha, fibrates, lipid metabolism and inflammation.
    Duval C; Fruchart JC; Staels B
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid metabolism and vascular disease.
    Semenkovich CF
    Trends Cardiovasc Med; 2004 Feb; 14(2):72-6. PubMed ID: 15030793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of mitogen-activated protein kinase pathway and co-activator CREP-binding protein on peroxisome proliferator-activated receptor-gamma-mediated transcription suppression of angiotensin II type 1 receptor gene.
    Sugawara A; Takeuchi K; Uruno A; Kudo M; Sato K; Ito S
    Hypertens Res; 2003 Aug; 26(8):623-8. PubMed ID: 14567501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
    Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction.
    Jackson SM; Parhami F; Xi XP; Berliner JA; Hsueh WA; Law RE; Demer LL
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2094-104. PubMed ID: 10479650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
    Tontonoz P; Nagy L
    Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.